Easton Pharmaceuticals (EAPH) Financial Statements

91 Followers

Easton Pharmaceuticals Financial Overview

Easton Pharmaceuticals's market cap is currently $1.34K. The company's EPS TTM is $-0.0003; its P/E ratio is -0.20; Easton Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 20	Dec 19	Dec 18
Income Statement
Total Revenue	$ 0.00	$ 1.56M	$ 378.59K
Gross Profit	$ 0.00	$ 201.40K	$ 106.91K
Operating Income	$ -189.00K	$ -322.00K	$ -124.00K
EBITDA	$ -8.33K	$ -6.59K	$ -124.00K
Net Income	$ -189.00K	$ -323.00K	$ -169.00K
Balance Sheet
Cash & Short-Term Investments	$ 23.19B	$ 247.97K	$ 66.30K
Total Assets	$ 10.19M	$ 17.17M	$ 10.15M
Total Debt	$ 2.48M	$ 8.46M	$ 2.18M
Net Debt	$ 2.48M	$ 8.21M	$ 2.11M
Total Liabilities	$ 3.28M	$ 10.08M	$ 3.01M
Stockholders' Equity	$ 6.91M	$ 7.10M	$ 7.14M
Cash Flow
Free Cash Flow	$ -207.34K	$ 491.88K	$ -6.86K
Operating Cash Flow	$ -188.54K	$ 510.68K	$ -6.86K
Investing Cash Flow	$ -18.80K	$ -18.80K	$ 0.00
Financing Cash Flow	$ 64.00	$ 1.12K	$ 18.37K

Currency in USD

Easton Pharmaceuticals Earnings and Revenue History

Income Statement >

Easton Pharmaceuticals Debt to Assets

Balance Sheet >

Easton Pharmaceuticals Cash Flow

Cash Flow >

Easton Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >